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Ca2 signals in neurons use specific temporal and spatial patterns to encode unambiguous information about crucial cellular functions.
To understand the molecular basis for initiation and propagation of inositol 1,4,5-trisphosphate (InsP3)-mediated intracellular Ca
2
signals, we correlated the subcellular distribution of components of the InsP3 pathway with measurements of agonist-induced intracel-
lular Ca2 transients in cultured rat hippocampal neurons and pheochromocytoma cells.We found specialized domainswith high levels
of phosphatidylinositol-4-phosphate kinase (PIPKI) and chromogranin B (CGB), proteins acting synergistically to increase InsP3
receptor (InsP3R) activity and sensitivity. In contrast, Ca
2 pumps in the plasmamembrane (PMCA) and sarco-endoplasmic reticulum
as well as buffers that antagonize the rise in intracellular Ca2 were distributed uniformly. By pharmacologically blocking
phosphatidylinositol-4-kinase and PIPKI or disrupting the CGB–InsP3R interaction by transfecting an interfering polypeptide frag-
ment,weproducedmajor changes in the initiation site andkinetics of theCa2 signal. This study shows that a limitednumber of proteins
can reassemble to form unique, spatially restricted signaling domains to generate distinctive signals in different regions of the same
neuron. The finding that the subcellular location of initiation sites and proteinmicrodomains was cell type specific will help to establish
differences in spatiotemporal Ca2 signaling in different types of neurons.
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Introduction
To control many diverse intracellular processes (Berridge, 1998),
neuronal Ca2 signals encode information via distinct spatio-
temporal patterns. Transient rises in cytoplasmic Ca2 concen-
tration ([Ca2]i) are generally restricted to specific cell compart-
ments such as the presynaptic terminal or postsynaptic spine,
regulating neurotransmission and synaptic modulation (Zucker,
1989; Yuste et al., 1999). It has recently been shown that release of
Ca2 from internal stores can also spread within a neuron as
regenerative waves (Nakamura et al., 1999; Kapur et al., 2001).
Little is known about the basic properties of internal Ca2 re-
lease, including the site of origin. Stimulation of muscarinic ace-
tylcholine receptors (mAChRs) in neuronally derived cells gives
rise to Ca2 signals initiating in the neurite (Johenning et al.,
2002). Similarly, in pyramidal neurons of the hippocampus and
neocortex, Ca2 transients evoked by synaptic activation of
metabotropic glutamate receptors (mGluRs) are initiated in the
proximal apical dendrite (Pozzo-Miller et al., 1996; Yeckel et al.,
1999; Kapur et al., 2001; Larkum et al., 2003). In many neurons,
the second messenger inositol 1,4,5-trisphosphate (InsP3) is the
main trigger for generating elevations in [Ca2]i emanating from
Ca2 channels in the endoplasmic reticulum (ER) (Nakamura et
al., 2000; Rizzuto, 2001; Johenning et al., 2002). A key to under-
standing the spatiotemporal characteristics of Ca2 signals is
thus likely to lie in the various components of the InsP3 pathway.
InsP3 is generated by phospholipase C (PLC)-mediated cleavage
of a phosphoinositide lipid precursor into InsP3 and diacylglycerol
(DAG) (Fig. 1). Phosphatidylinositol-4-kinase (PI4K) synthesizes
phosphatidylinositol-4-phosphate (PIP) from phosphatidylinositol
(PI). Two subtypes termed II and III, differing in their sensitivity to
the PI3K inhibitor wortmannin (Downing et al., 1996), have been
described previously (Barylko et al., 2001). PIP is metabolized by
phosphatidylinositol-4-phosphate-5-kinase (PIPK) to produce
phosphatidylinositol-4,5-bisphosphate (PIP2), the immediate InsP3
precursor. PIPKI is the main isoform in neurons (Wenk et al.,
2001). PIP2 is concentrated inplasmamembranes (Watt et al., 2002)
and is in itself an important cellular effector (Czech, 2003).
The superfamily of Ca2 release channels comprises three
Received Oct. 17, 2004; revised Jan. 28, 2005; accepted Jan. 31, 2005.
This work was supported by grants from the National Institutes of Health (GM63496, DK61747 to B.E.E., and
MH67830 to M.F.Y.), Whitehall Foundation (M.F.Y.), German National Merit Foundation (S.N.J. and C.-U.C.), and
Vetenskapsrådet, the Swedish Research Council (P.U.). We are grateful to J. Fitzpatrick, M. Nathanson, C. Schlecker,
A. Varshney,M. Estrada, and S. Krueger for thoughtful discussions and comments on thismanuscript and to A. Kolar
for invaluable help with the hippocampal neuron cultures.
Correspondence shouldbeaddressed toDr. Barbara E. Ehrlich, Department of Pharmacology, YaleUniversity, 333
Cedar Street, New Haven, CT 06520-8066. E-mail: barbara.ehrlich@yale.edu.
DOI:10.1523/JNEUROSCI.4313-04.2005
Copyright © 2005 Society for Neuroscience 0270-6474/05/252853-12$15.00/0
The Journal of Neuroscience, March 16, 2005 • 25(11):2853–2864 • 2853
isoforms of the InsP3 receptor (InsP3R)
and the ryanodine receptor (RyR). Al-
though the biophysical properties and dis-
tribution of the RyRs are similar, each
InsP3R isoform is characterized by a differ-
ent InsP3 affinity (Patel et al., 1999), Ca
2-
dependent inactivation (Bezprozvanny et
al., 1991; Hagar et al., 1998), tissue distri-
bution (Furuichi and Mikoshiba, 1995;
Sharp et al., 1999), and regulation by phos-
phorylation (Tang et al., 2003) and addi-
tional endogenous modulators. The ER-
resident high-capacity, low-affinity Ca2
storage proteins chromogranin A (CGA)
and CGB were found in a variety of neu-
roendocrine cells and neurons of the pe-
ripheral and central nervous systems
(Winkler and Fischer-Colbrie, 1992) and have recently gained
importance as activators of the InsP3R (Thrower et al., 2002,
2003).
Despite our extensive knowledge about many components of
the Ca2 signaling tool kit, it remains unclear how cells use the
different elements to achieve spatially and temporally distinct
Ca2 signals. Here, we use fluorescence immunocytochemistry
to demonstrate differential targeting of proteins enhancing and
inhibiting InsP3-mediated Ca
2 signaling in cultured hippocam-
pal neurons and neuron-like pheochromocytoma cells (PC12
cells) (Koizumi et al., 1999). With Ca2 imaging techniques, we
show that manipulation of regionally specific protein domains
modifies the kinetics and temporal aspects of neuronal Ca2
signals.
Materials andMethods
Cell culture and hippocampal neuron preparation. Rat adrenal pheochro-
mocytoma cells (PC12 cells) were purchased from American Type Cul-
ture Collection (Manassas, VA) and grown in high-glucose DMEM sup-
plemented with 10% heat-inactivated horse serum, 5% heat-inactivated
fetal calf serum, 25 U/ml penicillin, and 25g/ml streptomycin (all from
Invitrogen, Grand Island, NY) in poly-L-lysine-coated flasks (BD Bio-
sciences, Bedford, MA). Cells were cultured in a water-saturated atmo-
sphere at 37°C and 5%CO2. To induce differentiation, cells were diluted
to 3 104 ml1 and plated onto collagen-I-coated coverslips (BD Bio-
sciences) treatedwith 0.1% (w/v) poly-L-lysine (Peptide Institute, Osaka,
Japan) to promote adhesion. Cells were differentiated with 100 ng/ml
nerve growth factor (NGF) (AlomoneLaboratories, Jerusalem, Israel) for
7 d. Cultures were fed three times per week.
Low-density cultures of dissociated rat hippocampal neurons were
prepared using amodification of a protocol described previously (Brewer
et al., 1993). Hippocampi were dissected from Sprague Dawley rat em-
bryos (embryonic days 18–19), incubated for 15minwith 0.03% trypsin,
and dissociated using a fire-polished Pasteur pipette. Hippocampal cells
with glia were then plated at a density of 3–6 103 cm1 on coverslips
(Warner Instruments, Hamden, CT) coated with 0.1% (w/v) poly-L-
lysine (Peptide Institute) in Neurobasal medium supplemented with 5%
fetal calf serum, 0.5 mM glutamine, 2% B-27, 50 U/ml penicillin, 50
g/ml streptomycin (all from Invitrogen, Grand Island, NY), and 25 M
glutamate (Sigma, St. Louis, MO). Four hours after plating, the medium
was replaced with serum-free Neurobasal supplemented with 0.5 mM
glutamine, 2% B-27, 50 U/ml penicillin, and 50 g/ml streptomycin.
One-third of themediumwas replacedweekly. Cultureswere used 10–20
d after plating.
Transfection of PC12 cells. The pShooter-pCMV/myc/ER plasmid (In-
vitrogen, Carlsbad, CA) containing the cDNA for the near N-terminal
CGB peptide or a scrambled peptide and the pcDNA3.1 DsRed2-N1
construct (Clontech, Palo Alto, CA) used to verify transfection have been
described previously (Choe et al., 2004). Twenty to 30 hours after plating,
cells were cotransfected with 0.5g of pcDNA3.1DsRed2-N1 cDNA and
1.5 g of pShooter-pCMV/myc/ER with either the CGB fragment or the
scrambled peptide using 3.5l of Lipofectamine 2000 (Invitrogen, Carls-
bad, CA) per 35 mm well. Cells were then differentiated with NGF and
used 6–7 d after transfection.
To monitor intracellular PIP2, CFP-PLC1(PH) (the pleckstrin ho-
mology domain of PLC1 linked to cyan fluorescent protein) was gener-
ated and expressed into cells as described previously (Johenning et al.,
2004).
Antibodies and immunocytochemistry. Each InsP3R was detected using
isoform-specific antibodies. Rabbit polyclonal InsP3R1 and InsP3R2 an-
tibodies (1:100) were purchased from A.G. Scientific (San Diego, CA). A
mouse monoclonal antibody was used to label the N-terminal region of
the human InsP3R3 (1:100; BD Transduction Laboratories, Lexington,
KY). Similarly, each RyR isoform was identified using isoform-specific
antibodies, all kindly provided by Dr. Vincenzo Sorrentino (Universita
degli di Siena, Siena, Italy): mouse monoclonal RyR1 (1:100) and RyR2
(1:100) and rabbit polyclonal RyR3 (1:200). Rabbit polyclonal PIPKI
antibody (1:500) was a kind gift from Dr. G. di Paolo (Yale University,
New Haven, CT). The other antibodies used included rabbit polyclonal
PI4K (1:200; Upstate Biotechnology, Lake Placid, NY), rabbit poly-
clonal mGluR1 and mGluR5 (1:100; Chemicon, Temecula, CA), mouse
monoclonal PLC1 (1:100; Santa Cruz Biotechnology, Santa Cruz, CA),
goat polyclonal CGA (1:100; Santa Cruz Biotechnology), mouse mono-
clonal CGB (1:100; BD Transduction Laboratories), goat polyclonal
PMCA1 (1:100; Santa Cruz Biotechnology), goat polyclonal SERCA2
(sarco-endoplasmic reticulum, 1:50; Santa Cruz Biotechnology), and
mousemonoclonal parvalbumin (1:100; Chemicon). Primary antibodies
were visualized with fluorochrome-coupled secondary antibodies. The
secondary antibodies used were Alexa Fluor 488 and 568 coupled with
goat anti-rabbit and goat anti-mouse IgG and Alexa Fluor 488 and 594
coupled with donkey anti-goat IgG (all fromMolecular Probes, Eugene,
OR). Nuclei were stained by incubating the cells with TOPRO-3 (mono-
meric cyanine nucleic acid stain) for 20 min (1:200 in PBS; Molecular
Probes).
Cells were fixed with 4% (w/v) paraformaldehyde in PBS containing
4% (w/v) sucrose (PBSS), pH 7.4, for 20 min at room temperature and
permeabilizedwith 0.1% (v/v) TritonX-100 for 5min.Nonspecific bind-
ing sites were blocked by incubating the cells with PBSS containing 10%
normal goat serum (NGS) and 1%bovine serumalbumin for 45min. For
CGA, PMCA1, and SERCA2 detection, NGS was replaced by fetal calf
serum. Cells were exposed to primary and secondary antibodies diluted
in PBSS with 1% bovine serum albumin for at least 2 h and 1 h, respec-
tively. Labeled cells were visualized on an LSM510 META inverted con-
focal microscope (Zeiss, Oberkochen, Germany) using 40, 0.8 numer-
ical aperture (NA) and 63, 1.4 NA oil-immersion objectives. Averaging
eight frames reduced noise. Fluorochromes were excited with an argon
laser at 488 nm (Alexa 488) and a helium–neon laser at 543 nm (Alex 568
and 594) and 633 nm (TOPRO-3). The appropriate emission filters were
used for fluorescence detection.
Live cell imaging of the ER and mitochondria. PC12 cells on coverslips
Figure 1. Diagram of the inositol phosphate and lipid cycles. Inositol is symbolized by hexagons, the inorganic phosphate
groups are symbolized by small circles, and DAG is symbolized by a rectanglewith two zigzagged lines. Enzymes are in italics, and
inhibitors are underlined. CDP, Cytidine diphosphate; WT, wortmannin.
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were loadedwith 5MER-Tracker dye (Molec-
ular Probes) in growth medium for 30 min at
37°C. The coverslip was transferred to a super-
fusion chamber and mounted onto the stage of
an MRC-1024 confocal microscope (Bio-Rad,
Hercules, CA), equipped with a Tsunami Ti:S
laser and a Millenia X pump laser (Spectra-
Physics, Mountain View, CA). ER-Tracker was
excited at 790 nm by two-photon excitation.
Fluorescencewas observed at 500–540 nmwith
custom-built external detectors using a 63,
1.4 NA objective.
Mitochondria were labeled with 200 MMi-
toTracker Green FMdye (Molecular Probes) in
growth medium for 30 min at 37°C. An argon
laser at 488 nm was used for excitation. Fluo-
rescence was detected with appropriate emis-
sion filters. Cells were observed on a Zeiss
LSM510 upright confocal microscope using a
40, 0.8 NA water-immersion objective.
Ca2 fluorescence imaging. PC12 cells grown
on glass coverslips were loaded with 9 M
fluo-4AM in 20%Pluronic F-127 inDMSO(all
from Molecular Probes) for 20 min at 37°C in
extracellular solution containing (in mM) 124
NaCl, 2.5 KCl, 2 CaCl2, 2 MgCl2, 10 D-glucose,
25 NaHCO3 and 1.25 NaH2PO4. Before imag-
ing, cells were allowed an additional 5 min in
dye-free extracellular solution for deesterifica-
tion of the dye. The coverslip was used as the
bottom of an open superfusion chamber
mounted onto the stage of a Zeiss LSM510 up-
right confocal microscope. Cells were perfused
continuously with extracellular solution at 5
ml/min. Solution changes were accomplished
rapidly by means of a valve attached to a four-
chambered superfusion reservoir. Perfusion
with the muscarinic receptor agonist carbachol
started after the cells had reached a stable base-
line. An argon laser at 488 nm was used for
excitation, and the emission signal was detected
with the appropriate emission filter. Cells were
observed using a 40, 0.8 NA water-
immersion objective, and whole-cell images
were recorded every 200 ms for 4 min. In-
creases in [Ca2]i were expressed as the ratio of
fluorescence intensity F of fluo-4 over baseline
F0, calculated as the average of at least 10 frames
before fluorescence increase, and corrected for
background fluorescence Fb ((F  Fb)/(F0 
Fb)). Experiments were performed at 21°C.
For fluorescence imaging in hippocampal
neurons, whole-cell patch-recording pipettes
(2–4 M) were pulled from borosilicate glass
and filled with (in mM) 106 K-gluconate, 10
HEPES, 6 NaCl, 6 MgCl2, 0.2 EGTA, 2 ATP
(disodium salt), 0.4 GTP (monosodium salt),
20 phosphocreatine (dipotassium salt), and 50
Figure 2. Proteins activating and inhibiting InsP3-mediated Ca
2 signaling are targeted to distinct compartments in NGF-
differentiated PC12 cells. The subcellular localization was determined by indirect immunofluorescence as described in Materials
andMethods. Proteinswith an enhancing effect on Ca 2 signals are depicted in green (a), and proteins reducing Ca 2 levels are
shown in red (b). Nuclei are shown in blue. In a and b, the bottom panels show the quantification of the fluorescence intensity
along a typical neurite (shown as the red neurite in a miniature cell), plotted as a function of the distance from proximal (left) to
distal (right) sections of the cell. a, PIPKI and CGBwere highly concentrated in the growth cones and the branching points of the
neurites (arrows), suggesting a potential mechanism for spatiotemporally distinct Ca 2 signaling patterns. The same result was
obtained for CGA. PIP2, as monitored by visualizing CFP-PH, was located predominately in the plasma membrane of the growth
cones (arrows) and is shown in cyan. Amore uniformdistributionwas found for PI4K andPLC. The ER extended throughout the
4
cell, dominating in the soma and growth cones. b, In con-
trast, proteinsdecreasing [Ca 2]iwere either notdistributed
asymmetrically or predominated in the soma: immunoreac-
tivity for PMCA1andSERCA2wasdetected to the sameextent
in the cell body and the growth cones. Localization of parval-
bumin was mainly somatic with weaker staining in the neu-
rites. Mitochondria were distributed essentially evenly. Scale
bar, 20m.
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U/mlphosphocreatinekinase.Cellswereperfused
continuously at 1 ml/min with artificial CSF
(ACSF) containing (in mM) 130 NaCl, 3 KCl, 2
CaCl2, 1 MgCl2, 10 HEPES, and 5 D-glucose, pH
adjusted to 7.5. Whole-cell patch-clamp record-
ings were made from the soma with an npi SEC-
05LXamplifier (AdamsandListAssociates,West-
bury, NY) in discontinuous voltage-clampmode.
The resting membrane potential was typically
near 55 mV. Series resistance was between 10
and 20M. Neurons were stimulated with bath-
applied (S)-3,5-dihyroxyphenylglycine (DHPG)
(50M;Tocris,Bristol,UK)dissolveddirectly into
ACSF. A concentration of 10 M 6,7-dinitroqui-
noxaline-2,3-dione (DNQX) (Tocris) to block
non-NMDA receptors was always present in the
bathing solution. Tomeasure changes in [Ca2]i,
bis-fura-2 (100 M; Molecular Probes) was in-
cluded in the pipette solution and allowed to dif-
fuse into the neuron for at least 5 min before op-
tical recordings began. Fluorescence images were
recorded at 10 Hz with 380 nm excitation using a
cooled charge-coupled device camera (Quantix
57; Photometrics, Tuscon, AZ) mounted onto a
Zeiss upright fluorescence microscope equipped
with a 40, 0.8 NA water-immersion objective.
Membrane voltage was held at 65 mV to pre-
vent any contribution from Ca2 influx via volt-
age-gated channels. Relative changes in [Ca2]i
were quantified by calculating F/F0, where F0 is
the fluorescence intensity before stimulation (af-
ter subtracting background fluorescence), andF
is the change in fluorescence during neuronal ac-
tivity (corrected for bleaching). Pixels were






a)pyrimidine-5-one (R59022) were obtained
fromCalbiochem (La Jolla, CA).
Data analysis. Fluorescence intensity was
measured over regions of interest (ROI) in the
soma and the neurites. ROI were5 5m. In
PC12 cells, ROI over the cell body and the growth
cones were 80–100 m apart. In hippocampal
neurons, ROI were placed every 5–15 m from
the soma to distal sections of large caliber den-
drites. A 9-1 moving average filter was applied to
PC12 cell traces. The onset of the signalwas deter-
mined as the time point at which F/F0 began to
riseabove10%of the intervalbetweenF0 andFmax
for the first time (seeFig. 4a, arrows).The flux rate
was calculated as the slope of a line between the
data point at which the onset of the signal was
determined and the data point at which F/F0
reached 90% of the interval between F0 and Fmax.
The self-ratio method was used because it is a
measurement independent of factors such as dye
concentration, excitation intensity, and detector
efficiency. Statistical significance was tested using
the unpaired Student’s t test at p 0.05.
Results
Asymmetric subcellular distribution of proteins of the InsP3
signaling cascade in neuronally differentiated PC12 cells
To test whether the initiation site and release kinetics of intracel-
lular Ca2 signals were determined by a nonuniformdistribution
of proteins involved in InsP3-mediated Ca
2 release, we exam-
ined the localization of major components of the InsP3 signaling
pathway in NGF-differentiated PC12 cells. These elements were
labeled using protein-specific primary antibodies and fluores-
Figure 3. Continues
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cently tagged secondary antibodies and were visualized by confo-
cal microscopy (Fig. 2a,b). PLC and the wortmannin-sensitive
III isoform of PI4K (PI4K) were balanced evenly between the
soma and the neurite with no apparent concentration in either
cell compartment (Fig. 2a). The same results were obtained for
the other PI4K subtypes (data not shown). In contrast, the distri-
bution of PIPKI, the next step in InsP3 synthesis, was specifically
targeted to the growth cones and branching points of the neu-
rites. Prominent protein clusters at the tip of and in the course of
the processes of a cell were seen, whereas staining in the cell body
was weak in comparison. The bottom panels in Figure 2 show a
quantification of the fluorescence intensity along a typical neu-
rite, plotted as a function of the distance from proximal to distal
sections of the cell. When PIP2 levels were estimated bymonitor-
ing the location of a fusion protein containing the pleckstrin
homology domain of PLC1 linked to cyan fluorescent protein
CFP-PLC1(PH) (Johenning et al., 2004), the distribution was
found to follow the localization of PIPKI (Fig. 2a). We next
investigated the distribution of the chromogranin proteins,mod-
ulators of receptor activity from the luminal side of the Ca2
channel (Thrower et al., 2002, 2003). Both CGA and CGB were
highly concentrated in the neurites, especially at the growth
cones, and staining in the cell body was weak (Fig. 2a). Quantifi-
cation of the fluorescence intensity along a typical neurite is
shown below the immunofluorescence panel. Together with the
results for PIPKI, these findings suggested that protein domains
are in the position to enhance Ca2 signals via two distinct “ON
mechanisms”: (1) increased PIP2 levels that would augment
stimulus-induced InsP3 production and (2) increased sensitivity
of the InsP3R by chromogranin binding to the luminal side of the
receptor, which would allow faster activation of the InsP3R. To
confirm that differences in the distribution ofCa2 stores did not
account for the greater efficiency of neurites in generating Ca2
transients, we labeled live cells with ER-
Tracker dye. The ER extended throughout
the entire cell and was concentrated to the
same extent in the soma and growth cones
(Fig. 2a).
In support of our hypothesis that ON
mechanisms enhance localized Ca2 sig-
naling, we found no such striking distribu-
tion for the various “OFF mechanisms.”
Immunoreactivity for the Ca2-ATPases
in the plasma membrane (PMCA1) and
sarco-endoplasmic reticulum (SERCA2)
that extrude Ca2 from the cytoplasmwas
detected in the entire cell with an evenly
balanced ratio between the cell body and
its processes (Fig. 2b, with quantification
of the fluorescence intensity along a typical
neurite shown below each panel). Simi-
larly, mitochondria sequester Ca2 from
the cytosol, potentially terminating Ca2
signals. Labeling withMito-Tracker dye in
live cells showed that mitochondria were
distributed essentially uniformly (Fig. 2b).
The Ca2 buffer parvalbumin was more
concentrated in the soma and only showed
weak staining in the neurites (Fig. 2b), thus
displaying a pattern opposite to the ele-
ments associated with activation of intra-
cellular Ca2 signals (Fig. 2a).
Distinct subcellular distribution of InsP3 signaling proteins
in cultured hippocampal neurons
To determine whether asymmetric protein localization was a
general principle used by other cell types, we examined the spatial
distribution of components of the InsP3 pathway in cultured hip-
pocampal neurons (Fig. 3a,b). Fluorescence intensity was quan-
tified as described for Figure 2. In these cultures the majority of
the neurons had the size and shape expected of pyramidal cells.
The analysis of mGluRs focused on types 1 and 5, because these
subtypes are known to be components of the InsP3R signaling
pathway by their coupling with PLC via the G-protein Gq and
they represent the predominant isoforms involved in Ca2 sig-
naling in neurons from the hippocampus andmany other regions
of the brain (Nakamura et al., 2000). mGluR1 immunoreactivity
was detected in the entire neuron, extending from the cell body to
distal dendrites. In contrast, mGluR5 was confined to the soma,
and only faint staining was observed in proximal dendrites (Fig.
3a). This is similar to the localization of mAChRs in PC12 cells
(Johenning et al., 2002). The distribution of PLCwas essentially
uniform. PI4Kwas predominately localized in the cell body and
dendrites coming off the cell body up to the bifurcation. More
distal dendrites appeared weaker. We observed high concentra-
tions of PIPKI in perinuclear regions of the soma. Lower levels
were detected in distal parts of the neuron (Fig. 3a). InsP3R1 was
most prominent in the cell body and in the shafts of large-caliber
dendrites. The absence of InsP3R2 in hippocampal neurons
(Sharp et al., 1999)was confirmed; however, substantial InsP3R2-
specific immunoreactivity was associatedwith glial cells (data not
shown). We found small quantities of InsP3R3 restricted to the
soma. Distal dendrites were not labeled (Fig. 3a). RyR1 was
mainly localized in the soma, although some protein extended
into more distal parts of the cell, mostly large caliber dendrites.
Figure 3. a, Components activating the InsP3 pathway are concentrated in the soma and proximal dendrites of cultured
hippocampal neurons. Proteins were localized by indirect immunofluorescence, and fluorescence was quantified as outlined in
Figure 2. Activators of Ca 2 signaling are depicted in green. Nuclei are in blue. Cells with purely nuclear staining are glia.mGluR1
was detected throughout the neuron, reaching from the soma to distal dendrites. mGluR5, in contrast, was localized predomi-
nately in the cell body; staining in the dendrites was weak and restricted to proximal sections. A differential interference contrast
(DIC) image is shown on the right. PLC distribution was essentially uniform. Immunoreactivity for PI4K was found to be
ubiquitous with an emphasis on the soma and the apical dendrite up to the bifurcation. Staining for PIPKIwas especially strong
inperinuclear regionsof the cell bodyand in theproximal primarydendrite. InsP3R1was readily detected in the somaand the shaft
of large-caliber dendrites. Although therewas no evidence for InsP3R2 (data not shown), small levels of InsP3R3were localized in
the cell body. RyR1 staining was strong in the soma and extended into large dendrites. Little RyR2was found in central compart-
ments of the neuron. RyR3 was distributed throughout the cell; high levels were observed in the soma and dendritic spines. CGB
was localized exquisitely in the soma and shafts of large proximal dendriteswith no staining in distal parts of the cell. Scale bar, 20
m. b, Components inhibiting the InsP3 pathway are more uniformly distributed. Proteins were visualized as in Figure 3a.
Inhibitors are depicted in red. Even distribution lacking apparent concentrationwas found for PMCA1, SERCA2, and parvalbumin.
Scale bar, 20m.
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Weak staining for RyR2 was found in central compartments of
the neuron. RyR3 was distributed throughout the neuron with
particularly strong staining in the cell body and dendritic spines
(Fig. 3a). Finally, CGB was exquisitely targeted to the soma and
invaded only the proximal dendrites. No labeling in distal cell
compartments was observed (Fig. 3a).
The distribution of proteins reducing intracellular Ca2 levels
was similar to that found in NGF-treated PC12 cells (compare
Figs. 2b, 3b). The Ca2 pumps PMCA1 and SERCA2were readily
detected throughout the entire neuron lacking obvious subcellu-
lar localizations (Fig. 3b). Parvalbumin, a Ca2 buffer abundant
in many neuronal cell types (Baimbridge et al., 1992), was local-
ized to the same extent in the cell body and the dendrites (Fig. 3b).
Together, the soma and proximal dendrites of hippocampal neu-
rons in culture appear to concentrate many proteins able to trig-
ger and sustain intracellular Ca2 transients, whereas inhibiting
elements such as pumps and buffers were evenly balanced.
Protein domain composition predicts initiation site for
intracellular Ca2 signals
To test the hypothesis that the spatiotemporal pattern of Ca2
transients can be predicted by the subcellular localization of pro-
teins involved in InsP3-mediated Ca
2 signaling, we monitored
intracellular Ca2 transients in PC12 cells and cultured hip-
pocampal neurons. If the asymmetric location of chromogranins
and PIPKI influenced the signal initiation site, the Ca2 signal
should first appear in the branching points and growth cones of
the neurites of PC12 cells and in the soma or proximal dendrites
of hippocampal neurons.
When NGF-differentiated PC12 cells were stimulated by ap-
plication of the mAChR agonist carbachol, a rise in [Ca2]i was
observed in both the soma and the growth cones (Fig. 4a, top
left). The Ca2 signal clearly initiated in the neurite followed by
the cell body after a delay (see expanded time scale in Fig. 4a,
bottom left). Averaging over all cells revealed a latency of 0.78
0.28 s between the onset of theCa2 transient in the growth cones
and the soma (Fig. 4b, left). The signal was of greater amplitude
and reached peak values faster in the neurite (Fig. 4b, right). This
lower threshold for activation in the growth cones was observed
in 83% of cells analyzed (n	 12).
Cultured hippocampal neurons were stimulated with the se-
lective group I mGluR agonist DHPG (50 M). In an effort to
isolate Ca2 signals attributable to internal release from influx of
Ca2 through voltage-gated Ca2 channels, neurons with
pyramidal-like morphology were held in voltage-clamp mode at
resting or hyperpolarizing levels. To suppress network activity,
we included the ionotropic glutamate antagonist DNQX (10M)
in the perfusionmedia. Consistent with the distributions of CGB
and PIPKI, we only observed the onset of internal Ca2 release
in the soma or primary dendrite just proximal to the soma. Over-
all, the apparent site of initiation could be associated either with
the soma (38%) or the proximal primary dendrite (62%). Release
that began in the soma propagated distally toward the dendrite
(Fig. 5a), whereas release initiating in the proximal dendrites
propagated bidirectionally (Fig. 5c).
By plotting the latency between the onset of the signal in the
soma and in the distal dendrites as a function of increasing dis-
tance (Fig. 5b,d, left), it could be seen that the propagation veloc-
ity was not uniform. The Ca2 signal spread faster near the site of
initiation and slowed as it traveled out. There also was a gradual
decrease in amplitude and rate of rise as thewave spread along the
main dendritic trunk into distal branches (Fig. 5b,d, right). Ca2
transients near the soma were characterized by a greater magni-
tude and high flux rate; signals in the distal branches were low in
amplitude and rate of rise. A comparison of the kinetics of the
three analyzed parameters for a single neuron showed a high
degree of congruency. In all cells, the signal recorded at the initi-
ation site was always the greatest in amplitude and rate of rise
compared with the transients measured further away.
Functional chromogranin–InsP3R coupling contributes to
shaping Ca2 transients
Chromogranin proteins are predicted to be an enhancing ele-
ment of InsP3-mediated Ca
2 release (Thrower et al., 2002,
2003). To test this prediction, the chromogranin–InsP3R interac-
tion was inhibited by expressing a CGB polypeptide fragment
that has been shown to disrupt their functional coupling (Choe et
al., 2004). PC12 cells were transfected either with the chromo-
granin fragment or with a scrambled peptide as control, or were
not transfected. The distribution of the InsP3Rwas unchanged by
this treatment. When stimulated, cells transfected with the
Figure 4. Growth cones of PC12 cells are more effective than the soma at generating fast,
high-amplitude intracellular Ca 2 signals. PC12 cells were stimulated with 500 M bath-
applied carbachol for 60 s, and the consecutive rise in [Ca 2]i was detected and analyzed as
explained in Materials and Methods. a, The time course of the Ca 2 transients recorded in the
neurite and somaof a representative cell are shownon the left; an expanded time scale is shown
below. The time point of signal initiation is marked by black arrows. The right panel shows a
differential interference contrast image of typical cells. [Ca 2]i wasmonitored in the soma and
in the growth cones. Scale bar, 20m. b, On average, the Ca 2 signal initiated in the growth
cone followed by the soma after 0.78 0.28 s. The transient in the neurite was of greater
magnitude (1.97 0.41 vs 1.03 0.15) and rose faster (0.18 0.03 vs 0.07 0.01 s1).
Data in b are presented as the average of the number of cells in parentheses (SEM). *p
0.05; **p 0.01.
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scrambled peptide displayed increases in
intracellular Ca2 in the growth cone first
with the signal appearing in the soma after
a delay of 2.0 s (Fig. 6a). This order was
reversed in cells expressing the CGB frag-
ment: Ca2 levels rose first in the soma
followed by the neurite after 2.0 s (Fig. 6b).
Overall, there was no difference in the sig-
nal delay between untransfected cells and
cells transfected with the scrambled pep-
tide (1.78  0.54 vs 1.83  0.33 s). The
CGB fragment, however, significantly al-
tered the site of initiation in favor of the
soma (0.83  0.59 s) (Fig. 6c). These
data provide a strong argument for the in-
volvement of chromogranins in shaping
intracellular Ca2 transients. Unexpect-
edly, when the chromogranin–InsP3R
couplingwas inhibited, themagnitude and
rate of rise of the Ca2 signal were de-
pressed to a greater extent in the cell body.
Again, no differencewas observed between
controls and cells transfected with the
scrambled peptide (Fig. 6d). The average
values for the neurites were as follows
(percentage of controls): 102  11 and
106 26 for amplitude and flux rate with
the scrambled peptide, respectively; 63 
12 and 35 13 for amplitude and flux rate
with the CGB fragment, respectively. The
average values for the somawere as follows
(percentage of controls): 91 14 and 91
30 for amplitude and flux rate with the
scrambled peptide, respectively; 31  10
and 14  7 for amplitude and flux rate
with the CGB fragment, respectively.
Reduction of PIP2 levels alters the site of
signal initiation
The asymmetric distribution of PIPKI
lead to the suggestion that higher PIP2 lev-
els in “hot spots” could play a role in ex-
plaining the distinct spatiotemporal pat-
tern of Ca2 signals. We therefore
inhibited PIPKI function by depriving
the enzyme of its substrate PIP by treating
NGF-differentiated PC12 cells with wort-
mannin, an inhibitor of type III PI4K
(Downing et al., 1996; Meyers and Cant-
ley, 1997). Cells were preincubated for 20
min in growth medium supplemented
with 10 M wortmannin, a dose sufficient
to block all PI4KIII activity and decrease
PIP levels (Sorensen et al., 1998). Treated
cells were then stimulated with carbachol,
and Ca2 signals were recorded. In con-
trast to untreated cells, the rise in [Ca2]i
in a representative cell pretreated with
wortmannin clearly initiated in the soma
(Fig. 7a). Both the amplitude and flux rate
were greatly depressed in the growth cone,
whereas the soma seemed less affected.
The average temporal delay for wortman-
Figure 5. Ca 2 signals in hippocampal neurons initiate in the soma or proximal primary dendrite. Hippocampal neurons in
whole-cell patch-clamp configuration were stimulated with 50 M DHPG by bath application. An elevation in [Ca 2]i was
measured as explained in Materials and Methods. a, A typical experiment showing the rise in [Ca 2]i occurred first in the soma
adjacent to the proximal apical dendrite and propagated distally (white arrow). The colored boxes in the right panel designate the
location on the neuron where the correspondingly colored traces were recorded. b, The latency to rise in [Ca 2]i and the
magnitude and flux rateweremeasured along themain dendritic trunk.Wavepropagation velocity, as approximatedby the slope
of the left graph, was not linear with distance. Ca 2 spread faster near the site of initiation and slowed with increasing distance
(left). Similarly, the amplitude and flux rate of the Ca 2 signal were highest at the place of origin and decreased with growing
distance (right). c, In another neuron, signal initiationwasobserved in theproximal primarydendrite. TheCa 2wavepropagated
bidirectionally toward the cell body and into thedendrites (white arrows). The onset of the rise in [Ca 2]i ismarkedby thedashed
line. Themain trunkalwayspreceded theobliquedendrites as indicatedby theblue traces.d, The latency to rise and theamplitude
and flux ratewerequantified as inb. Thepropagation velocity againwasnonlinear, and thehighest and fastest signalswere found
at the initiation site. Scale bars: a, c, 20m.
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nin was1.87 0.52 s, indicating that the
rise in [Ca2]i in the cell body preceded
the growth cones by almost 2 s (Fig. 7e).
The latency between the onset of the signal
in the neurite and the soma was 1.31 
0.29 s for control cells. Thus, incubation
with wortmannin reversed the order in
which the signal initiated in the two cell
compartments. This result strongly impli-
cates PIPKI as an important component
in determining the site of signal initiation.
Wortmannin not only affects PI4K but
also PI3K and myosin light chain kinase
(Nakanishi et al., 1995). Therefore, we
needed to show that the shift in the site of
signal origin was achieved by inhibition of
PI4K and not by another kinase. First,
PC12 cells were incubated for 20 min with
increasing doses of wortmannin (from 1
nM to 50 M), and the carbachol-induced
changes in [Ca2]i were recorded (Fig. 7b–
d). Wortmannin concentrations in the
nanomolar range are sufficient to potently
inhibit PI3K (Sorensen et al., 1998). How-
ever, no effect on any of the parameters
analyzed was observed below 1 M (Table
1). Between 1 and 50 M, the ability of the
growth cone to generate early Ca2 re-
sponses was markedly reduced, indicated
by the gradual decrease in measured la-
tency. At 50M, the neurite trailed behind
the soma by 2.6 s (Fig. 7b). Very similar
kinetics were observed for the magnitude.
The dose–response curve shows that un-
der control conditions the growth cones
released twofoldmore Ca2 from their in-
tracellular stores compared with the cell
body and that this proportion changed
with increasing wortmannin doses (Fig.
7c). The ratio of the magnitude obtained
under control conditions and with 50 M
wortmannin shows that there was a de-
crease by a factor of 6 in the cell body, and
the amplitude in the neurite declined by a
factor of 48 (Fig. 7c, inset). Consistent with
the reduction in latency to rise andmagni-
tude, the flux rate of the Ca2 signal de-
creased in the same wortmannin range
(Fig. 7d). This parameter reflects InsP3R
open probability during the main activa-
tion phase (Ogden and Capiod, 1997).
Again, a decrease was observed only at
wortmannin concentrations 
1 M. The
ratio of reduction, as calculated for the
amplitude, was 12 for the growth cones
and 5 for the soma (Fig. 7d, inset).
The IC50 value for the effect of wort-
mannin on the parameters analyzed was
7.5 M. This is three orders of magni-
tude higher than the concentrations
needed to inhibit PI3K (Sorensen et al.,
1998). To further demonstrate that the ef-
fect achieved with wortmannin can be ex-
Figure 6. Blocking the stimulating effect of CGB on the InsP3R changes the initiation site. PC12 cells were transfected with a
CGB polypeptide fragment to interfere with the CGB–InsP3R interaction. Experiments using a scrambled peptide with a random
amino acid sequence served as controls. a, Traces were recorded, as outlined in Figure 4, from the soma and growth cones of a
representative cell transfectedwith the scrambled peptide. An expanded time scale is shownon the right. Therewas no change in
the initiation site of the Ca 2 signal (black arrows) compared with untransfected cells. b, In cells transfected with the CGB
fragment, the rise in [Ca 2]i occurred in the soma first (black arrows). An expanded time scale is shown on the right. c, Quanti-
fication of all cells analyzed illustrates that the fragment significantly shifted the initiation site of the Ca 2 signal to the soma
comparedwith untransfected cells or cells transfectedwith the scrambled peptide (latency to rise,0.83 0.59 vs 1.78 0.54
vs 1.83 0.33 s, respectively).d, The amplitude and flux rateweremeasured in all three settings and are shown for the somaand
neurite. Although the parameters were not affected by transfection with the scrambled peptide, the CGB fragment markedly
decreased them. Data in c and d are presented as the average of the number of cells in parentheses (SEM). n.s., Not significant.
*p 0.05; **p 0.01.
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plained by PI4K inhibition, we preincubated PC12 cells for 20
min with 100M LY294002, a selective inhibitor of PI3K (Vlahos
et al., 1994; Suh and Hille, 2002) and recorded the carbachol-
induced Ca2 signals. There was no effect on the latency, ampli-
tude, or rate of rise of [Ca2]i (Fig. 7e; Tables 1, 2). Furthermore,
depleting the cell of PI, which is the substrate of PI4K, also would
be expected to affect the spatiotemporal
pattern ofCa2 transients. PC12 cells were
pretreated for 10 min with 40 M R59022,
a DAG kinase inhibitor. This interrupts
the lipid cycle after DAG, and PI cannot be
replenished from phosphatidic acid (Ford
et al., 2003) (Fig. 1). As expected, all three
parameters were altered as seen for wort-
mannin (Fig. 7e; Tables 1, 2). These results
support the prediction that reduction of
PIP2 levels by (indirect) PIPKI inhibition
is the mechanism for the change in spatio-
temporal Ca2 signaling (Fig. 7a) and that
asymmetric levels of PIP2 within a cell play
a role in shaping the pattern of Ca2
signals.
Discussion
The experiments described here demon-
strate that neuronal cells canmodulate the
kinetics and initiation sites of Ca2 tran-
sients by differentially distributing pro-
teins involved in the InsP3 signaling cas-
cade. Our observations suggest that
proteins that increase InsP3R open proba-
bility by increasing PIP2 production
(PIPKI) and receptor sensitization
(chromogranin proteins) are purposefully
targeted to specific sections of the neuron.
These protein elements become the build-
ing blocks of specialized domains enabling
the cell to generate early, high-amplitude,
and fast Ca2 signals in these compart-
ments. In the neuron types investigated
here, the location of the highest density of
PIPKI and CGB predicted the site of
Ca2 signal initiation.
Previously, the localization of Ca2 re-
lease channels in PC12 cells was examined
(Johenning et al., 2002). The low-
threshold InsP3 sensor InsP3R1 was found
throughout the entire cell, whereas the
high-threshold sensor InsP3R3 was tar-
geted predominately to the soma. There-
fore, the distribution of InsP3Rs alone can-
not explain the differences in Ca2
signaling in PC12 cells unless heterotet-
rameric InsP3R (combinations of type 1
and 3 InsP3R) are formed in the cell body
with a significantly lower affinity for InsP3.
PLC-coupled receptors in the plasma
membrane for the muscarinic agonist car-
bachol, mAChRs, were found mainly in
the soma and only in smaller clusters along
the neurite (Johenning et al., 2002), again
suggesting that the localization of this pro-
tein cannot account for the signaling dif-
ferences observed. In contrast, the distri-
bution of PIPKI andCGB in PC12 cells described in this study is
an explanation.
In hippocampal neurons, many elements enhancing InsP3-
mediated Ca2 signaling were localized predominately in the
soma or proximal apical dendrite, most notably PIPKI and
Figure 7. Wortmannin shifts the initiation site of the Ca 2 signal to the soma by reduction of PIP2. a, PC12 cells were treated
with 10M wortmannin for 20 min and stimulated with 500M bath-applied carbachol for 60 s. An elevation in [Ca 2]i was
monitored and analyzed as in Figure 4. The time course of the Ca 2 signals recorded in the neurite and soma of a representative
cell are shown on the left; amagnification is shown on the right. The site of initiation shifted strikingly in favor of the soma (black
arrows) comparedwithuntreated cells (latency to rise,1.870.52vs1.310.29 s;e).b, PC12 cellswere incubated for 20min
with different concentrations of wortmannin, and Ca 2 signals were elicited as above. The temporal delay between the rise in
[Ca 2]i in the growth cones and somawas plotted against increasingwortmannin concentrations. A sigmoid functionwas fitted
to the dose–response curve. c, Themagnitude of the signalwas plotted and fittedwith a sigmoid function as inb. The inset shows
the ratio of values obtained under control conditions to values measured with 50M wortmannin and represents a measure for
the efficacy of wortmannin inhibition in the two cell compartments. The amplitude declined 48-fold in the growth cones as
opposed to sixfold in the soma.d, Thedose–responsecurve for the flux ratewasobtainedasdescribed inb. As shown in the inset, the flux
rate was decreased by a factor of 12 in the growth cones andmerely by 5 in the cell body. Wortmannin concentrations1M do not
inhibitPI4KIIIandconsequentlydidnotaffectanyoftheanalyzedparameterswhencomparedwithcontrolvalues. Increasingwortmannin
to50Mresulted inaconsiderable reductionofeachof theparameters.All threegraphswerecongruent,andthe IC50 valuewasbetween
5 and7.5M. e, Incubationwith 100M LY294002, a selective inhibitor of PI3K, did not affect the initiation site comparedwith controls
(1.780.54vs1.310.29s),whereas40MR59022,aDAGkinaseblocker,shiftedittothesoma(0.490.40s), furthersuggesting
theobservedeffectwascausedbyPI4KIII inhibition.Datapoints inb–dareaveragesofat leasteight cellsSEM.Data inearepresented
as the average of the number of cells in parentheses (SEM). n.s., Not significant. **p 0.01.
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CGB, whereas Ca2 buffers and pumps
were distributed uniformly (Fig. 3a,b). As
predicted by our model and consistent
with previous reports (Pozzo-Miller et al.,
1996; Yeckel et al., 1999; Kapur et al., 2001;
Larkum et al., 2003), the Ca2 signal be-
gan in the proximal dendrites or soma
(Fig. 5a,c), regions that also exhibited the
highest amplitude and flux rate for the
Ca2 transients (Fig. 5b,d). Moreover, the
Ca2 wave spread faster in central com-
partments where high concentrations of
proteins activating the InsP3 pathway were
located and slowed in the periphery where
levels of these proteins were diminished
(Fig. 5b,d). Together, these results support
the concept that protein domains enhance
intracellular Ca2 signaling and that con-
clusions generated from experiments with
neuronally differentiated PC12 cells can be adapted to other types
of neurons.
The striking effect on the initiation site and kinetics of the
Ca2 transient achieved by blocking PI4KIII and, indirectly,
PIPKI with wortmannin (Fig. 7) clearly implies a role for PIP
and PIP2 as immediate InsP3 precursors in shaping spatiotempo-
ral Ca2 signaling patterns. The expectationwas that the decrease
in phospholipid levels after incubation with wortmannin would
affect the soma and growth cones to the same extent, because
PI4K distribution was uniform (Fig. 2a). However, the relative
decrease of the measured parameters for Ca2 signals as repre-
sented by the ratio of the control values to the values obtained
with full wortmannin inhibition was not the same for the soma
and the growth cone (Fig. 7c,d, insets; Table 1). This meant that
factors in addition to phospholipid levels alone needed to be
considered. The chromogranin proteins were likely candidates
because of their asymmetric distribution similar to PIPKI (Fig.
2a). By disrupting the interaction between CGB and the InsP3R
with a CGB polypeptide fragment (Choe et al., 2004), the site of
initiation was shifted to the soma (Fig. 6b,c). This result shows
that the functional channel complex consisting of the InsP3R and
CGB is crucial for shaping intracellular Ca2 signals. The obser-
vation that the CGB fragment altered the site of initiation in favor
of the cell body but reduced the amplitude and flux rate to a
greater extent in this compartment was unexpected (Fig. 6d). The
possibility that the CGB fragment was localized to the soma was
ruled out because examination of myc-tagged CGB fragment
confirmed that the polypeptide is expressed to the same degree in
the cell body and the neurites (data not shown). Another possibility
is that not all CGB–InsP3R interaction is disrupted in the growth
cones because of the abundance of nativeCGB, further emphasizing
the importanceofCGB for localCa2 signaling in theneurites as the
initiation site is shifted despite functional complexes remaining.
With the components of the Ca2 signaling tool kit identified
here, it is possible to propose a model to explain the diverse spatio-
temporal patterns of InsP3-mediated neuronal Ca
2 signals. When
PIP is abundant in the entire cell, the first rate-limiting step in InsP3
synthesis isPIPKI activity. PIP2 levels are considerablyhigher in the
neurite as a consequence of the higher density of PIPKI in the
growth cones as described here (Fig. 2a) and in other systems in
which the synapses of primary neurons are rich in PIPKI and PIP2
(Micheva et al., 2001; Wenk et al., 2001). The large pool of PIP2
substrate for PLC is vital for compensating for the asymmetric
localization ofmAChRs, the secondmajor factor determining InsP3
generation. Given the low density of receptors in the growth cones,
only small amounts of PLC can be activated after stimulation with
muscarinic agonists. Consequently, PIP2 cannot be efficiently me-
tabolized in the neurite to yield high InsP3 levels. Previous experi-
ments have already excluded the possibility of increased InsP3 pro-
duction in the neurite as the mechanism underlying the observed
temporal delay (Johenning et al., 2002). The InsP3 levels in the neu-
rite still suffice to generate signals of highermagnitude and flux rate
compared with the soma, because the InsP3Rs in the growth cones
are more sensitive to their ligand and a better surface/volume ratio
favors theneurite.Higher sensitivity is conferredbymultiple factors,
including the locationof higher-affinity InsP3R1s andhigh chromo-
granin levels (Fig. 2a).
Inhibiting PI4KIII with wortmannin drastically reduces PIP
levels uniformly throughout the cell (Sorensen et al., 1998), and
the PIP concentration becomes rate limiting in InsP3 synthesis.
The nonuniform distribution of PIPK is of no further conse-
quence. The low density of mAChRs in the neurite is no longer
sufficient to generate adequate InsP3 concentrations in the neu-
rite, because the growth cone is dependent on an abundant sup-
ply of PIP2 to ensure that activation of PLC to cleave PIP2 is
efficient. This can be seen as the disproportionate decline in am-
plitude and flux rate of [Ca2]i in the neurite in relation to the
soma (Fig. 7c,d; Table 1). Under these conditions, high CGB
levels are insufficient to adequately sensitize the InsP3R, and the
synergism between receptor activation by elevated InsP3 precur-
sors and high chromogranin concentrations breaks down. Sup-
port for the notion that synergistic receptor activation in the
neurite is crucial for efficient intracellular Ca2 signaling comes
from the observation that early interference in the InsP3 pathway
Table 1. Effects of kinase inhibitors and peptide fragments on the kinetics of Ca2 transients
Amplitude (percentage of change vs control) Flux rate (percentage of change vs control) n
Wortmannin (1M, soma) 10 16a 17 13a 20
Wortmannin (1M, neurite) 1 16a 2 22a 20
Wortmannin (50M, soma) 78 4 (p 0.001) 83 1 (p 0.01) 8
Wortmannin (50M, neurite) 98 2 (p 0.01) 92 1 (p 0.05) 8
LY294002 (100M, soma) 10 26a 10 32a 8
LY294002 (100M, neurite) 3 19a 5 27a 9
R59022 (40M, soma) 64 10 (p 0.01) 71 9 (p 0.01) 5
R59022 (40M, neurite) 73 3 (p 0.05) 81 2 (p 0.001) 7
Scrambled peptide (soma) 9 14a 9 30a 7
Scrambled peptide (neurite) 2 11a 6 26a 14
CGB fragment (soma) 69 10 (p 0.01) 86 7 (p 0.05) 7
CGB fragment (neurite) 37 12 (p 0.05) 65 13 (p 0.05) 12
In three sets of experiments, cells were incubated with the indicated concentrations of (1) wortmannin (20 min) and (2) LY294002 (20 min) or R59022 (10
min) or (3) were transfected with the scrambled peptide or CGB fragment. Untreated cells served as controls for the lipid kinase inhibitors and the scrambled
peptide, the latter as the control for the fragment.
aNot significant.
Table 2. Effects of kinase inhibitors and peptide fragments on the initiation site of
Ca2 transients
Control (s) Treatment (s) n
Wortmannin (1M) 0.78 0.28 0.15 0.33a 20
Wortmannin (50M) 0.78 0.28 2.60 0.40 (p 0.001) 8
LY294002 (100M) 1.31 0.29 1.78 0.54a 9
R59022 (40M) 1.31 0.29 0.49 0.40 (p 0.01) 7
Scrambled peptide 1.76 0.52 1.83 0.34a 9
CGB fragment 1.83 0.34 0.83 0.59 (p 0.001) 12
The delay between the onset of the signal in the neurite and the soma is displayed ast(soma neurite). In three sets
of experiments, cells were incubated with the indicated concentrations of (1) wortmannin (20 min) and (2)
LY294002 (20 min) or R59022 (10 min) or (3) were transfected with the scrambled peptide or CGB fragment.
Untreated cells served as controls for the lipid kinase inhibitors and the scrambled peptide, the latter as the control
for the fragment.
aNot significant.
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with wortmannin affects the magnitude and rate of rise of the
Ca2 transient to a greater degree than late inhibition with the
CGB fragment (Table 1).
Additional variables are certain to influence InsP3-mediated
signaling. Phosphorylation of the InsP3R in the neurite increasing
sensitivity for its ligand (Tang et al., 2003) may play a role as well
as differing densities of InsP3R1 and InsP3R3 throughout the cell
(Shuai and Jung, 2003). Although RyRs do not seem to influence
signal initiation, the higher concentration of RyRs in the soma
could compensate for the high-threshold InsP3R3, facilitating Ca
2
release (Johenning et al., 2002). Higher-ordered structures that link
together receptors, G-proteins, PLCs, and InsP3Rs by scaffolding
proteins such as Vesl/Homer guarantee specificity of signal trans-
ductionandpreventunwantedcross talkbetweendifferent signaling
pathways (Delmas et al., 2002). Overall, the interactions among the
components of theCa2 signaling cascade in the cells describedhere
indicate how a set of parameters can bemanipulated to achieve cell-
specific responses.
One purpose for Ca2 signaling domains in growth cones is
particularly intriguing. Ca2, among other secondmessengers, is
known to regulate neurite outgrowth and guidance of axons by
extracellular factors (Hong et al., 2000; Nishiyama et al., 2003).
The Ca2 elevation in growth cones necessary tomodulate attrac-
tion and repulsion is essentially attributed to influx from the extra-
cellular space through plasma membrane channels and efflux from
RyRs.Ourdatapoint to thepossibility that, in addition,Ca2 release
from InsP3-sensitive internal stores may be specifically boosted by
theproteindomains found in thegrowthcones tocontribute toaxon
guiding (Takei et al., 1998).
In conclusion,weprovidehere experimental data to elucidate the
mechanism underlying distinct spatiotemporal Ca2 signaling pat-
terns in neuronal cells. We have identified the growth cones of
neuron-like pheochromocytoma cells as special cell compartments
equipped with unique protein machinery to efficiently generate
Ca2 transients.By favoring theCa2“source”over the“sink,” these
cells establish protein domains to enhance InsP3-mediated Ca
2
signaling, ensuring speed and spatial localization of Ca2 release.
Furthermore, we demonstrated that this system is in use in hip-
pocampal neurons, suggesting a general principle in the cell biology
of neurons and possibly nonexcitable cells.
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